Markets

Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split To Maintain Nasdaq Listing

March 14, 2025 — 03:21 pm EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Hepion Pharmaceuticals (HEPA) will implement a 1-for-50 reverse stock split, effective March 17, 2025, with trading on a split-adjusted basis beginning March 18, 2025, under the same ticker.

The split aims to raise the stock price to meet Nasdaq Capital Market's $1.00 minimum bid price requirement.

As a result, every 50 shares will be consolidated into one share, reducing the total outstanding shares from 54.25 million to 1.08 million. No fractional shares will be issued—any fractional holdings will be rounded up.

The split will proportionally adjust outstanding stock options and warrants but will not impact stockholder ownership percentages or voting power.

HEPA is currently trading at $0.0236 or 37.5661% lower on the Nasdaq Capital Market.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Markets
Stocks Mentioned

Latest Articles
Data is currently not available